Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi

Updated on: December 26,2023

Colonoscopy-screening does not prevent colorectal cancer as well as previously assumed

by Mathilde Coraline, Aarvold Bakke,University of OsloCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0On October 10 the world's first randomized study on usi

Updated on:December 26,2023

Precision physical activity prescriptions improve survival in colon cancer

by Pennington Biomedical Research CenterCredit: Unsplash/CC0 Public DomainPhysical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon

Updated on: December 26,2023

Precision physical activity prescriptions improve survival in colon cancer

by Pennington Biomedical Research CenterCredit: Unsplash/CC0 Public DomainPhysical activity may be associated with improved outcomes for patients undergoing postoperative treatment for Stage III colon

Updated on:December 26,2023

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on: January 11,2024

New bone cancer drug improves survival rates by 50% in preclinical trials

byUniversity of East AngliaCredit: Pixabay/CC0 Public DomainResearchers at the University of East Anglia have developed a new drug that works against all of the main types of primary bone cancer

Updated on:January 11,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on: June 22,2024

Negative fecal tests tied to low risk for advanced colorectal cancer

by Lori SolomonThere was a low risk for advanced neoplasia after multiple rounds of negative fecal immunochemical tests (FIT) in people undergoing surveillance colonoscopy, according to a study publis

Updated on:June 22,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on: January 26,2024

Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma

byUniversity of Miami Leonard M. Miller School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers conducting a Phase 2 clinical trial at Sylvester Comp

Updated on:January 26,2024

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on: August 27,2024

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on:August 27,2024

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have formulated a tuneable, nanoengineered bioink for tumor modeling which contai

Updated on: January 04,2024

Enhanced tumor modeling using Laponite bioinks for 3D bioprinting

by Terasaki Institute for Biomedical InnovationScientists from the Terasaki Institute for Biomedical Innovation (TIBI) have formulated a tuneable, nanoengineered bioink for tumor modeling which contai

Updated on:January 04,2024

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many

Updated on: March 26,2024

Time for a 'Weed-Free January?' How cannabis users could benefit from a 'dry' month

by James MacKillop,The ConversationCredit: RDNE Stock project from PexelsBy now, most are familiar with the idea of Dry January, a voluntary month without alcohol that follows a month when many

Updated on:March 26,2024

Testosterone is an ally of macrophages in the battle against adrenal cancers

byCNRSMacrophages attacking adrenal tumor in male mouse. Credit: © Julie Olabe CNRS/GReDWhy are cancers of the adrenal glands more common among women? Why are prognoses worse for them? A team of

Updated on: December 22,2023

Testosterone is an ally of macrophages in the battle against adrenal cancers

byCNRSMacrophages attacking adrenal tumor in male mouse. Credit: © Julie Olabe CNRS/GReDWhy are cancers of the adrenal glands more common among women? Why are prognoses worse for them? A team of

Updated on:December 22,2023

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on: January 08,2024

A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer

by Vall d'Hebron Institute of OncologyA total of 166 patients with mCRCBRAF-V600Ewere included in the study from discovery (n = 46), validation (n = 52) and control (n = 68) cohorts. WES of

Updated on:January 08,2024

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c

Updated on: May 05,2024

New, revised topics released in ACR appropriateness criteria

(HealthDay)—The latest edition of the American College of Radiology (ACR) Appropriateness Criteria has been released and includes 188 diagnostic imaging and interventional radiology topics, with 908 c

Updated on:May 05,2024

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on: May 09,2024

Clinical trial shows durvalumab plus ceralasertib boosted immune response in lung cancer patients

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung

Updated on:May 09,2024